Cemtrex Files Proforma Financials for $7.06M Invocon Acquisition, Revealing Increased Debt and Net Loss
CETX is trading near its 52-week low of $0.586 (1.6% above the low).
Summary
Cemtrex Inc. filed an amendment to its January 8, 2026 8-K, providing audited and unaudited financial statements for its $7.06 million acquisition of Invocon Inc., along with proforma financials showing a higher combined net loss due to acquisition financing.
Key Events · M&A and Partnerships · CETX
-
Acquisition Financials Disclosed
Cemtrex filed audited financial statements for Invocon (acquired on Jan 8, 2026) for the year ended December 31, 2024, and unaudited financials for the nine months ended September 30, 2025.
-
Proforma Impact Revealed
Unaudited proforma financial information shows the combined entity's net loss increasing to $(29.35) million, primarily due to interest expense from the $7.025 million acquisition financing note.
-
Significant Debt Burden
The $7.06 million cash acquisition, funded by a large note, represents a substantial financial commitment relative to Cemtrex's market capitalization, adding to the company's existing debt load.
Analysis · CETX · Manufacturing
This amended filing provides critical financial transparency regarding Cemtrex's acquisition of Invocon, which was completed on January 8, 2026. While Invocon itself was profitable, the proforma financial statements reveal that the $7.06 million cash acquisition, largely funded by a $7.025 million note, significantly increases Cemtrex's debt and interest expense. This results in a higher proforma net loss for the combined entity, which is a material concern for a company that recently disclosed a "going concern" warning and is currently trading near its 52-week low. Investors should note the substantial financial burden introduced by this acquisition, despite the added revenue from Invocon.
At the time of this filing, CETX was trading at $0.59 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $6M. The 52-week trading range was $0.59 to $42.60. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.